Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × Letrozole × Clear all

Phase

Phase 2 4 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 75 Polycystic Ovary Syndrome 9 Neoplasm Metastasis 5 Neoplasms, Hormone-Dependent 3 Infertility 3 Carcinoma, Lobular 3 Carcinoma, Ductal, Breast 3 Osteoporosis 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms, Male 2 Advanced Breast Cancer 2 Unilateral Breast Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Obesity 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Low Grade Serous Ovarian Cancer 1 Infertility, Female 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2+ Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Bone Diseases, Metabolic 1

Interventions

Dexamethasone 21 Rituximab 13 Paclitaxel 10 Gemcitabine 10 Cisplatin 10 pomalidomide 9 Lenalidomide 9 Carboplatin 8 Bortezomib 8 Cyclophosphamide 7 Drug Therapy 5 Cytarabine 5 selinexor 4 daratumumab 4 carfilzomib 4 Temozolomide 4 Doxorubicin 4 Docetaxel 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 ibrutinib 3 Vincristine 3 Prednisone 3 Cetuximab 3 Calcium Dobesilate 3 galiximab 2 eculizumab 2 durvalumab 2 blinatumomab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06760637 2026-03-02

FourLight-3

Pfizer

Phase 3 Recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡